JACC. CardioOncology (Dec 2019)
OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia
- Hiroyuki Kiriyama, MD,
- Junichi Ishida, MD,
- Hiroshi Kadowaki, MD,
- Takeshi Iwasa, MD,
- Arihiro Kiyosue, MD,
- Satoshi Kodera, MD,
- Jiro Ando, MD,
- Hiroshi Akazawa, MD,
- Issei Komuro, MD
Affiliations
- Hiroyuki Kiriyama, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan; Address for correspondence: Dr. Hiroyuki Kiriyama, Department of Cardiovascular Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
- Junichi Ishida, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan
- Hiroshi Kadowaki, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan
- Takeshi Iwasa, MD
- Department of General Internal Medicine, National Cancer Center Hospital, Tokyo, Japan
- Arihiro Kiyosue, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan
- Satoshi Kodera, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan
- Jiro Ando, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan
- Hiroshi Akazawa, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan
- Issei Komuro, MD
- Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan
- Journal volume & issue
-
Vol. 1,
no. 2
pp. 318 – 321